Login to Your Account



Other News To Note


Wednesday, May 1, 2013
• Pluristem Therapeutics Inc., of Haifa, Israel, said independent researchers from the University of Queensland, Australia, showed blood flow was maintained with no adverse hemodynamic effects following infusion of the company's placental eXpanded (PLX) cells in a human lung model of pulmonary arterial hypertension.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription